![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2025
Herold, Stephanie 
ORCID: https://orcid.org/0000-0002-8335-8790; Schmidt, Christian; Visco, Carlo; Tilch, Marie-Kristin; Ohler, Anke; Unterhalt, Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Hoenig, Elisabeth; Singer, Susanne; Tucci, Alessandra; Pott, Christiane; Ladetto, Marco; Hess, Georg und Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249
(2025):
The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatment.
In: BMC Cancer, Bd. 25, 1370
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-8335-8790; Schmidt, Christian; Visco, Carlo; Tilch, Marie-Kristin; Ohler, Anke; Unterhalt, Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Hoenig, Elisabeth; Singer, Susanne; Tucci, Alessandra; Pott, Christiane; Ladetto, Marco; Hess, Georg und Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249
(2025):
The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatment.
In: BMC Cancer, Bd. 25, 1370
[PDF, 1MB]
2022
Tilch, Marie-Kristin; Visco, Carlo; Kinda, Sandra; Hermine, Olivier; Kohn, Milena; Besson, Caroline; Lamure, Sylvain; Dulery, Remy; Ragaini, Simone; Eyre, Toby A.; Meerten, Tom van; Ohler, Anke; Eckerle, Steffen; Dreyling, Martin; Hess, Georg; Gine, Eva und da Silva, Maria Gomes
(2022):
Outcome of COVID-19 in Patients With Mantle Cell Lymphoma-Report From the European MCL Registry.
In: Hemasphere, Bd. 6, Nr. 5, e0711